Experience from a pilot site: a review of long-term outcomes of women referred to colposcopy with cytology-negative, HPV-positive cervical smears
pdf

Keywords

Cervical cancer
Cervical smears
screening
Colposcopy
Human papilloma virus

Abstract

 

 

 

https://doi.org/10.48037/mbmj.v8i4.65
pdf

References

NHS Choices. HPV vaccine. London: NHS; 2017 [updated 31/10/2017]. Available from: https://www.nhs.uk/conditions/vaccinations/hpv-humanpapillomavirus-vaccine/ (accessed 30.6.19).

Cancer Research UK. Cervical cancer incidence statistics. London: Cancer Research UK; 2018 . Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/cervical-cancer (accessed 30.6.19).

National Cancer Registration and Analysis Service. Cervical cancer incidence and screening coverage. London: Public Health England; 2018. Available from: http://www.ncin.org.uk/publications/data_briefings/cervical_incidence_and_screening (accessed 30.6.19).

Cancer Research UK. Cervical cancer mortality statistics. Cancer Research UK; 2018. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/cervical-cancer/mortality (accessed 30.6.19).

Public Health England. Cervical screening: programme overview London: Public Health England; 2015. Available from: https://www.gov.uk/guidance/cervical-screeningprogramme-overview (accessed 30.6.19).

Nobelprize.org. The 2008 Nobel Prize in physiology or medicine: press release. Nobelprize.org; 2008 [updated 2014]. Available from: https://www.nobelprize.org/nobel_prizes/medicine/laureates/2008/press.html (accessed 30.6.19).

World Health Organisation. Human papilloma vaccines WHO position paper. Weekly Epidemiological Record 2009;15(84):117-32.

World Health Organisation. Human papillomavirus (HPV) and cervical cancer. World Health Organisation; 2016 [updated June 2016]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer (accessed 30.6.19).

Dallenbach-Hellweg G, Trunk M J, von Knebel Doeberitz M. Premalignant lesions. In: Schoder G, editor. A Colour Atlas of Histopathology. 2nd ed. Heidelberg, Germany: Springer; 2006. p. 82-7.

Cancer Research UK. HPV and cancer. London: Cancer Research UK; 2016 [updated 02/09/2016]. Available from: https://www.cancerresearchuk.org/about-cancer/causes-of-cancer/infections-eg-hpv-and-cancer/does-hpv-cause-cancer (accessed 30.6.19).

University Hospitals of Morecambe Bay. Progression from normal cervix to invasive cancer Colposcopy; 2018.

World Health Organisation. Cervical cancer screening in developing countries: Report of a WHO consultation Geneva: World Health Organisation; 2002.

Sudenga S, Shrestha S. Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancer. International Journal of Infectious Diseases 2013;17(4):e216-220. Available from: https://doi.org/10.1016/j.ijid.2012.12.027

Cancer Research UK. Cervical cancer risk factors. London: Cancer Research UK; 2018. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/cervical-cancer#heading-Four (accessed 30.6.19).

Chatzistamatiou K, Moysiadis T, Vryzas D, et al. Cigarette smoking promotes infection of cervical cells by high-risk human papillomaviruses, but not subsequent E7 oncoprotein expression. International Journal of Molecular Sciences 2018;19(2):E422. Available from: https://doi.org/10.3390/ijms19020422

Sarian LOZ, Derchain SFM, Pitta D, Morais SS, Rabelo- Santos SH. Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ). Journal of Clinical Virology 2004;31(4):271-274. Available from: https://doi.org/10.1016/j.jcv.2004.05.012

Ogilvie GS, van Niekerk D, Krajden M, et al. Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL Randomized Clinical Trial. JAMA 2018; 320(1):43-52. Available from: https://doi.org/10.1001/jama.2018.7464